THE USE OF REAL-WORLD EVIDENCE IN HTA OF CLASS III MEDICAL DEVICES IN EUROPE

被引：0
|
作者：
Klein, P. [1 ]
de Groot, S. [2 ]
Blommestein, H. M. [2 ]
Pongiglione, B. [3 ]
Torbica, A. [4 ]
Al, M. J. [2 ]
机构：
[1] Inst Med Technol Assessment, Rotterdam, Netherlands
[2] Erasmus Univ, Rotterdam, Netherlands
[3] SDA Bocconi Sch Management, Milan, Italy
[4] Bocconi Univ, Milan, MI, Italy
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RW3
引用
收藏
页码：S758 / S758
页数：1
相关论文
共 50 条
  • [1] Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal
    Pongiglione, Benedetta
    Torbica, Aleksandra
    Blommestein, Hedwig
    de Groot, Saskia
    Ciani, Oriana
    Walker, Sarah
    Dams, Florian
    Blankart, Rudolf
    Mollenkamp, Meilin
    Kovacs, Sandor
    Tarricone, Rosanna
    Drummond, Mike
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
  • [2] ANALYSIS OF REAL-WORLD EVIDENCE AND REAL-WORLD DATA BY CONITEC, BRAZILIAN HTA AGENCY
    Nita, M. E.
    Riveros, B. S.
    Vaz, P.
    Mussolino, F.
    VALUE IN HEALTH, 2016, 19 (03) : A286 - A286
  • [3] Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment
    Timbie, Justin W.
    Kim, Alice Y.
    Concannon, Thomas W.
    VALUE IN HEALTH, 2021, 24 (12) : 1792 - 1798
  • [4] The Future of Registries in the Era of Real-world Evidence for Medical Devices
    Fleurence, Rachael L.
    Blake, Kathleen
    Shuren, Jeffrey
    JAMA CARDIOLOGY, 2019, 4 (03) : 197 - 198
  • [5] USE OF REAL-WORLD EVIDENCE IN ADVANCED THERAPY MEDICINAL PRODUCT (ATMP) HTA DECISIONS
    Watson, C.
    Jones, G.
    Miller, R.
    VALUE IN HEALTH, 2020, 23 : S663 - S663
  • [6] Use of real-world data and evidence for medical devices: a qualitative study of key informant interviews
    Polisena, Julie
    Jayaraman, Gayatri
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (06) : 579 - 584
  • [7] How real-world data compensate for scarce evidence in HTA
    George, Elisabeth
    ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2016, 112 : S23 - S26
  • [8] GLOBAL USE OF NORDIC REAL-WORLD EVIDENCE: A SYSTEMATIC REVIEW OF PUBLISHED LITERATURE AND HTA SUBMISSIONS
    Kaushik, P.
    Grip, Toresson E.
    Lueza, B.
    Arya, S.
    Singh, N.
    Nanda, S.
    Grover, R.
    Afaque, A.
    Syal, K.
    VALUE IN HEALTH, 2023, 26 (12) : S531 - S531
  • [9] DOES REAL-WORLD EVIDENCE PLAY A ROLE IN DECISION-MAKING BY HTA BODIES FOR MEDICAL TECHNOLOGIES?
    Hartley, L.
    Gildea, L.
    Mordin, M.
    Long, J.
    D'Souza, V
    Kinderas, M.
    Ling, C.
    Warttig, S.
    VALUE IN HEALTH, 2023, 26 (12) : S434 - S435
  • [10] THE USE OF PUBLISHED REAL-WORLD EVIDENCE IN HTA: AN ANALYSIS OF THE EVIDENCE BASE OF COMPANY SUBMISSIONS IN 2016 NICE APPRAISALS
    Van Lier, H.
    de Boeck, M.
    Edwards, V
    Hanekamp, E.
    Hartog, T. E.
    Richmond, G.
    van den Broek, R.
    VALUE IN HEALTH, 2017, 20 (09) : A410 - A410
12345